Bering Partners II, L.P.

13F Holdings History for Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

Symbol: CHRS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 7.6M shares
Security Ownership: 6.5%

Evgeny Zaytsev ("Zaytsev") ownership in Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS)

2025-11-04 - Evgeny Zaytsev ("Zaytsev") has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.6M shares of Coherus Oncology, Inc. Common Stock, $0.0001 par value per share (CHRS). This represents 6.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Evgeny Zaytsev ("Zaytsev")	6.5%		$12.5M	7.6M			$1.64	13G	9/5/2025	4 Nov 2025 18:44:44